Kanzius Cancer Research Foundation awarded $700,000

The Kanzius Cancer Research Foundation in Erie has been awarded $700,000 in funding through the U.S. Department of Health and Human Services (HHS) to help develop the novel radio frequency wave cancer treatment championed by the late John Kanzius.

“John Kanzius envisioned an innovative treatment for cancer that has the potential to save thousands of lives,” said Dahlkemper. “I am proud to support the mission of the Kanzius Cancer Research Foundation and help secure federal resources for the Kanzius Non-invasive Radiowave Cancer Treatment project. Radio frequency treatment research not only brings hope to those diagnosed with cancer, but it also brings the promise of quality jobs in Erie .”

The funds will be used to purchase critical laboratory equipment for observing cells before and after using the Kanzius Radio Frequency Device and for confirming laboratory results. Some of the laboratory equipment includes a dynamic light scattering instrument, Cellometer, flow cytometry laser upgrades and ICP mass spectroscopy.

“Cancer is very personal; it has dramatically touched all of our lives in one way or another. What a perfect affirmation of hope, especially during this holiday season, to receive these funds introduced by Congresswoman Dahlkemper,” said Mark Neidig, executive director of the Kanzius Cancer Research Foundation. “On behalf of our foundation, and the millions of cancer patients and their families around the world, thank you for believing in the potentials of our work.”

John Kanzius was the CEO and Manager of Therm Med, LLC, and spent his lengthy career in broadcast engineering, management and ownership. When Kanzius was diagnosed with a rare form of B-cell leukemia, he drew on his years of experience in broadcast and electrical engineering to envision a better way to treat cancer using physics and the use of non-invasive radio frequency waves. Kanzius passed away in February as a result of his cancer.

Leave a Reply